nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—head and neck cancer—peripheral nervous system neoplasm	0.223	0.55	CtDrD
Docetaxel—skin cancer—peripheral nervous system neoplasm	0.182	0.45	CtDrD
Docetaxel—ABCB1—peripheral nervous system neoplasm	0.0726	1	CbGaD
Docetaxel—TUBB2B—Vincristine—peripheral nervous system neoplasm	0.0229	0.0644	CbGbCtD
Docetaxel—TUBB6—Vincristine—peripheral nervous system neoplasm	0.0229	0.0644	CbGbCtD
Docetaxel—TUBB3—Vincristine—peripheral nervous system neoplasm	0.0229	0.0644	CbGbCtD
Docetaxel—TUBB4A—Vincristine—peripheral nervous system neoplasm	0.0229	0.0644	CbGbCtD
Docetaxel—TUBB2A—Vincristine—peripheral nervous system neoplasm	0.0229	0.0644	CbGbCtD
Docetaxel—TUBB8—Vincristine—peripheral nervous system neoplasm	0.0229	0.0644	CbGbCtD
Docetaxel—TUBB1—Vincristine—peripheral nervous system neoplasm	0.0192	0.0539	CbGbCtD
Docetaxel—TUBB4B—Vincristine—peripheral nervous system neoplasm	0.0192	0.0539	CbGbCtD
Docetaxel—TUBB—Vincristine—peripheral nervous system neoplasm	0.0192	0.0539	CbGbCtD
Docetaxel—ABCC10—Vincristine—peripheral nervous system neoplasm	0.0147	0.0412	CbGbCtD
Docetaxel—ABCC10—Etoposide—peripheral nervous system neoplasm	0.0134	0.0377	CbGbCtD
Docetaxel—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.00919	0.0258	CbGbCtD
Docetaxel—ABCC10—Doxorubicin—peripheral nervous system neoplasm	0.00916	0.0257	CbGbCtD
Docetaxel—ABCG2—Topotecan—peripheral nervous system neoplasm	0.00887	0.0249	CbGbCtD
Docetaxel—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.00666	0.0187	CbGbCtD
Docetaxel—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.00615	0.0173	CbGbCtD
Docetaxel—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.00609	0.0171	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.00609	0.0171	CbGbCtD
Docetaxel—ABCC1—Vincristine—peripheral nervous system neoplasm	0.00566	0.0159	CbGbCtD
Docetaxel—ABCC1—Etoposide—peripheral nervous system neoplasm	0.00519	0.0146	CbGbCtD
Docetaxel—CYP1B1—Doxorubicin—peripheral nervous system neoplasm	0.00498	0.014	CbGbCtD
Docetaxel—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.00457	0.0128	CbGbCtD
Docetaxel—ABCC2—Vincristine—peripheral nervous system neoplasm	0.00419	0.0118	CbGbCtD
Docetaxel—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.00391	0.011	CbGbCtD
Docetaxel—ABCC2—Etoposide—peripheral nervous system neoplasm	0.00384	0.0108	CbGbCtD
Docetaxel—ABCG2—Vincristine—peripheral nervous system neoplasm	0.00379	0.0106	CbGbCtD
Docetaxel—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.00354	0.00994	CbGbCtD
Docetaxel—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.00353	0.00992	CbGbCtD
Docetaxel—ABCG2—Etoposide—peripheral nervous system neoplasm	0.00347	0.00975	CbGbCtD
Docetaxel—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0032	0.00899	CbGbCtD
Docetaxel—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0032	0.00899	CbGbCtD
Docetaxel—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0028	0.00786	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0028	0.00786	CbGbCtD
Docetaxel—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.00262	0.00736	CbGbCtD
Docetaxel—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.00237	0.00665	CbGbCtD
Docetaxel—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00222	0.00623	CbGbCtD
Docetaxel—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0021	0.0059	CbGbCtD
Docetaxel—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.00192	0.0054	CbGbCtD
Docetaxel—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00192	0.00539	CbGbCtD
Docetaxel—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00178	0.00501	CbGbCtD
Docetaxel—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00137	0.00384	CbGbCtD
Docetaxel—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00127	0.00358	CbGbCtD
Docetaxel—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00125	0.00352	CbGbCtD
Docetaxel—GHRHR—brainstem—peripheral nervous system neoplasm	0.00103	0.0916	CbGeAlD
Docetaxel—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.000853	0.0024	CbGbCtD
Docetaxel—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.000818	0.0023	CbGbCtD
Docetaxel—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00075	0.00211	CbGbCtD
Docetaxel—MAP2—nerve—peripheral nervous system neoplasm	0.000738	0.0658	CbGeAlD
Docetaxel—MAP2—ganglion—peripheral nervous system neoplasm	0.000729	0.065	CbGeAlD
Docetaxel—MAPT—trigeminal ganglion—peripheral nervous system neoplasm	0.000578	0.0516	CbGeAlD
Docetaxel—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.000511	0.00144	CbGbCtD
Docetaxel—GHRHR—cerebellum—peripheral nervous system neoplasm	0.000506	0.0451	CbGeAlD
Docetaxel—MAP4—trigeminal ganglion—peripheral nervous system neoplasm	0.000455	0.0406	CbGeAlD
Docetaxel—MAP4—brainstem—peripheral nervous system neoplasm	0.000402	0.0359	CbGeAlD
Docetaxel—Cabazitaxel—ABCB1—peripheral nervous system neoplasm	0.000373	0.553	CrCbGaD
Docetaxel—MAP2—trigeminal ganglion—peripheral nervous system neoplasm	0.000358	0.0319	CbGeAlD
Docetaxel—MAP2—parotid gland—peripheral nervous system neoplasm	0.000338	0.0301	CbGeAlD
Docetaxel—KIF11—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.000317	0.129	CbGdCrCtD
Docetaxel—MAP2—brainstem—peripheral nervous system neoplasm	0.000317	0.0283	CbGeAlD
Docetaxel—Paclitaxel—ABCB1—peripheral nervous system neoplasm	0.000302	0.447	CrCbGaD
Docetaxel—TUBB4A—trigeminal ganglion—peripheral nervous system neoplasm	0.000277	0.0247	CbGeAlD
Docetaxel—TUBB2B—trigeminal ganglion—peripheral nervous system neoplasm	0.000267	0.0239	CbGeAlD
Docetaxel—TUBB—trigeminal ganglion—peripheral nervous system neoplasm	0.000253	0.0226	CbGeAlD
Docetaxel—MAPT—cerebellum—peripheral nervous system neoplasm	0.000252	0.0225	CbGeAlD
Docetaxel—TUBB2B—parotid gland—peripheral nervous system neoplasm	0.000252	0.0225	CbGeAlD
Docetaxel—TUBB2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000252	0.0225	CbGeAlD
Docetaxel—TUBB6—trigeminal ganglion—peripheral nervous system neoplasm	0.000248	0.0221	CbGeAlD
Docetaxel—TUBB4A—brainstem—peripheral nervous system neoplasm	0.000245	0.0218	CbGeAlD
Docetaxel—TUBB—parotid gland—peripheral nervous system neoplasm	0.000239	0.0213	CbGeAlD
Docetaxel—TUBB2A—parotid gland—peripheral nervous system neoplasm	0.000237	0.0212	CbGeAlD
Docetaxel—TUBB6—parotid gland—peripheral nervous system neoplasm	0.000234	0.0209	CbGeAlD
Docetaxel—BCL2—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.000229	0.0933	CbGdCrCtD
Docetaxel—ABCC10—trigeminal ganglion—peripheral nervous system neoplasm	0.000217	0.0194	CbGeAlD
Docetaxel—TUBB4B—trigeminal ganglion—peripheral nervous system neoplasm	0.000216	0.0192	CbGeAlD
Docetaxel—ABCC10—parotid gland—peripheral nervous system neoplasm	0.000205	0.0183	CbGeAlD
Docetaxel—TUBB4B—parotid gland—peripheral nervous system neoplasm	0.000203	0.0182	CbGeAlD
Docetaxel—TUBB3—cerebellum—peripheral nervous system neoplasm	0.000198	0.0177	CbGeAlD
Docetaxel—MAP4—cerebellum—peripheral nervous system neoplasm	0.000198	0.0177	CbGeAlD
Docetaxel—BCL2—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.000191	0.0778	CbGdCrCtD
Docetaxel—BCL2—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.000191	0.0778	CbGdCrCtD
Docetaxel—BCL2—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000191	0.0778	CbGdCrCtD
Docetaxel—BCL2—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000191	0.0778	CbGdCrCtD
Docetaxel—EGFR—cerebellum—peripheral nervous system neoplasm	0.000178	0.0159	CbGeAlD
Docetaxel—MAP2—cerebellum—peripheral nervous system neoplasm	0.000156	0.0139	CbGeAlD
Docetaxel—ABCC1—parotid gland—peripheral nervous system neoplasm	0.000145	0.0129	CbGeAlD
Docetaxel—BCL2—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.059	CbGdCrCtD
Docetaxel—BCL2—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.059	CbGdCrCtD
Docetaxel—ABCG2—trigeminal ganglion—peripheral nervous system neoplasm	0.000127	0.0114	CbGeAlD
Docetaxel—TUBB4A—cerebellum—peripheral nervous system neoplasm	0.000121	0.0108	CbGeAlD
Docetaxel—ABCG2—parotid gland—peripheral nervous system neoplasm	0.00012	0.0107	CbGeAlD
Docetaxel—KIF11—Teniposide—Etoposide—peripheral nervous system neoplasm	0.000119	0.0483	CbGdCrCtD
Docetaxel—TUBB2B—cerebellum—peripheral nervous system neoplasm	0.000117	0.0104	CbGeAlD
Docetaxel—TUBB—cerebellum—peripheral nervous system neoplasm	0.00011	0.00985	CbGeAlD
Docetaxel—TUBB2A—cerebellum—peripheral nervous system neoplasm	0.00011	0.0098	CbGeAlD
Docetaxel—TUBB6—cerebellum—peripheral nervous system neoplasm	0.000108	0.00966	CbGeAlD
Docetaxel—TUBB6—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	9.9e-05	0.0403	CbGdCrCtD
Docetaxel—TUBB6—Vitamin A—Tretinoin—peripheral nervous system neoplasm	9.9e-05	0.0403	CbGdCrCtD
Docetaxel—ABCC10—cerebellum—peripheral nervous system neoplasm	9.48e-05	0.00846	CbGeAlD
Docetaxel—TUBB4B—cerebellum—peripheral nervous system neoplasm	9.41e-05	0.0084	CbGeAlD
Docetaxel—KIF11—Vinblastine—Vincristine—peripheral nervous system neoplasm	8.17e-05	0.0333	CbGdCrCtD
Docetaxel—TUBB6—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	7.5e-05	0.0305	CbGdCrCtD
Docetaxel—CYP1B1—cerebellum—peripheral nervous system neoplasm	7.46e-05	0.00665	CbGeAlD
Docetaxel—TUBB6—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	6.92e-05	0.0282	CbGdCrCtD
Docetaxel—TUBB6—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	6.92e-05	0.0282	CbGdCrCtD
Docetaxel—TUBB6—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	6.92e-05	0.0282	CbGdCrCtD
Docetaxel—TUBB6—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	6.92e-05	0.0282	CbGdCrCtD
Docetaxel—ABCC1—cerebellum—peripheral nervous system neoplasm	6.71e-05	0.00598	CbGeAlD
Docetaxel—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	6.27e-05	0.0056	CbGeAlD
Docetaxel—ABCG2—cerebellum—peripheral nervous system neoplasm	5.55e-05	0.00495	CbGeAlD
Docetaxel—TUBB6—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	5.24e-05	0.0214	CbGdCrCtD
Docetaxel—TUBB6—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	5.24e-05	0.0214	CbGdCrCtD
Docetaxel—ABCB1—cerebellum—peripheral nervous system neoplasm	2.74e-05	0.00244	CbGeAlD
Docetaxel—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	2.51e-05	0.000237	CcSEcCtD
Docetaxel—Anorexia—Etoposide—peripheral nervous system neoplasm	2.51e-05	0.000237	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	2.5e-05	0.000236	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	2.5e-05	0.000236	CcSEcCtD
Docetaxel—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	2.5e-05	0.000236	CcSEcCtD
Docetaxel—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	2.49e-05	0.000235	CcSEcCtD
Docetaxel—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	2.49e-05	0.000234	CcSEcCtD
Docetaxel—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	2.49e-05	0.000234	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	2.48e-05	0.000234	CcSEcCtD
Docetaxel—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	2.47e-05	0.000233	CcSEcCtD
Docetaxel—Hypotension—Etoposide—peripheral nervous system neoplasm	2.46e-05	0.000232	CcSEcCtD
Docetaxel—Pain—Cisplatin—peripheral nervous system neoplasm	2.46e-05	0.000232	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	2.45e-05	0.000231	CcSEcCtD
Docetaxel—Neutropenia—Epirubicin—peripheral nervous system neoplasm	2.43e-05	0.000229	CcSEcCtD
Docetaxel—Asthenia—Alitretinoin—peripheral nervous system neoplasm	2.42e-05	0.000228	CcSEcCtD
Docetaxel—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000227	CcSEcCtD
Docetaxel—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	2.4e-05	0.000226	CcSEcCtD
Docetaxel—Pruritus—Alitretinoin—peripheral nervous system neoplasm	2.39e-05	0.000225	CcSEcCtD
Docetaxel—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	2.37e-05	0.000223	CcSEcCtD
Docetaxel—Paraesthesia—Etoposide—peripheral nervous system neoplasm	2.37e-05	0.000223	CcSEcCtD
Docetaxel—Weight increased—Epirubicin—peripheral nervous system neoplasm	2.36e-05	0.000223	CcSEcCtD
Docetaxel—Weight decreased—Epirubicin—peripheral nervous system neoplasm	2.35e-05	0.000222	CcSEcCtD
Docetaxel—Dyspnoea—Etoposide—peripheral nervous system neoplasm	2.35e-05	0.000221	CcSEcCtD
Docetaxel—Somnolence—Etoposide—peripheral nervous system neoplasm	2.34e-05	0.000221	CcSEcCtD
Docetaxel—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	2.34e-05	0.000221	CcSEcCtD
Docetaxel—Asthenia—Vincristine—peripheral nervous system neoplasm	2.33e-05	0.00022	CcSEcCtD
Docetaxel—Pneumonia—Epirubicin—peripheral nervous system neoplasm	2.33e-05	0.00022	CcSEcCtD
Docetaxel—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	2.32e-05	0.000218	CcSEcCtD
Docetaxel—Infestation—Epirubicin—peripheral nervous system neoplasm	2.32e-05	0.000218	CcSEcCtD
Docetaxel—Vomiting—Dactinomycin—peripheral nervous system neoplasm	2.31e-05	0.000218	CcSEcCtD
Docetaxel—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	2.31e-05	0.000218	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	2.3e-05	0.000216	CcSEcCtD
Docetaxel—Rash—Dactinomycin—peripheral nervous system neoplasm	2.29e-05	0.000216	CcSEcCtD
Docetaxel—Decreased appetite—Etoposide—peripheral nervous system neoplasm	2.29e-05	0.000216	CcSEcCtD
Docetaxel—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	2.28e-05	0.000215	CcSEcCtD
Docetaxel—Renal failure—Epirubicin—peripheral nervous system neoplasm	2.28e-05	0.000215	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	2.27e-05	0.000214	CcSEcCtD
Docetaxel—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	2.27e-05	0.000214	CcSEcCtD
Docetaxel—Fatigue—Etoposide—peripheral nervous system neoplasm	2.27e-05	0.000214	CcSEcCtD
Docetaxel—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	2.27e-05	0.000214	CcSEcCtD
Docetaxel—Jaundice—Epirubicin—peripheral nervous system neoplasm	2.26e-05	0.000213	CcSEcCtD
Docetaxel—Stomatitis—Epirubicin—peripheral nervous system neoplasm	2.26e-05	0.000213	CcSEcCtD
Docetaxel—Pain—Etoposide—peripheral nervous system neoplasm	2.25e-05	0.000212	CcSEcCtD
Docetaxel—Constipation—Etoposide—peripheral nervous system neoplasm	2.25e-05	0.000212	CcSEcCtD
Docetaxel—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	2.25e-05	0.000212	CcSEcCtD
Docetaxel—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	2.25e-05	0.000212	CcSEcCtD
Docetaxel—Dizziness—Alitretinoin—peripheral nervous system neoplasm	2.23e-05	0.00021	CcSEcCtD
Docetaxel—Diarrhoea—Vincristine—peripheral nervous system neoplasm	2.22e-05	0.00021	CcSEcCtD
Docetaxel—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	2.19e-05	0.000206	CcSEcCtD
Docetaxel—Weight increased—Doxorubicin—peripheral nervous system neoplasm	2.19e-05	0.000206	CcSEcCtD
Docetaxel—Epistaxis—Epirubicin—peripheral nervous system neoplasm	2.18e-05	0.000206	CcSEcCtD
Docetaxel—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	2.17e-05	0.000205	CcSEcCtD
Docetaxel—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	2.17e-05	0.000205	CcSEcCtD
Docetaxel—Nausea—Dactinomycin—peripheral nervous system neoplasm	2.16e-05	0.000204	CcSEcCtD
Docetaxel—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	2.16e-05	0.000204	CcSEcCtD
Docetaxel—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	2.15e-05	0.000203	CcSEcCtD
Docetaxel—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	2.15e-05	0.000203	CcSEcCtD
Docetaxel—Dizziness—Vincristine—peripheral nervous system neoplasm	2.15e-05	0.000203	CcSEcCtD
Docetaxel—Vomiting—Alitretinoin—peripheral nervous system neoplasm	2.15e-05	0.000202	CcSEcCtD
Docetaxel—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	2.14e-05	0.000202	CcSEcCtD
Docetaxel—Infestation—Doxorubicin—peripheral nervous system neoplasm	2.14e-05	0.000202	CcSEcCtD
Docetaxel—Rash—Alitretinoin—peripheral nervous system neoplasm	2.13e-05	0.000201	CcSEcCtD
Docetaxel—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	2.13e-05	0.0002	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	2.12e-05	0.0002	CcSEcCtD
Docetaxel—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	2.12e-05	0.0002	CcSEcCtD
Docetaxel—Headache—Alitretinoin—peripheral nervous system neoplasm	2.11e-05	0.000199	CcSEcCtD
Docetaxel—Renal failure—Doxorubicin—peripheral nervous system neoplasm	2.11e-05	0.000199	CcSEcCtD
Docetaxel—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	2.1e-05	0.000198	CcSEcCtD
Docetaxel—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	2.09e-05	0.000197	CcSEcCtD
Docetaxel—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	2.09e-05	0.000197	CcSEcCtD
Docetaxel—Jaundice—Doxorubicin—peripheral nervous system neoplasm	2.09e-05	0.000197	CcSEcCtD
Docetaxel—Rhinitis—Epirubicin—peripheral nervous system neoplasm	2.08e-05	0.000196	CcSEcCtD
Docetaxel—Abdominal pain—Etoposide—peripheral nervous system neoplasm	2.08e-05	0.000196	CcSEcCtD
Docetaxel—Body temperature increased—Etoposide—peripheral nervous system neoplasm	2.08e-05	0.000196	CcSEcCtD
Docetaxel—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	2.08e-05	0.000196	CcSEcCtD
Docetaxel—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	2.08e-05	0.000196	CcSEcCtD
Docetaxel—Hepatitis—Epirubicin—peripheral nervous system neoplasm	2.08e-05	0.000196	CcSEcCtD
Docetaxel—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	2.07e-05	0.000195	CcSEcCtD
Docetaxel—Vomiting—Vincristine—peripheral nervous system neoplasm	2.07e-05	0.000195	CcSEcCtD
Docetaxel—Asthenia—Cisplatin—peripheral nervous system neoplasm	2.06e-05	0.000195	CcSEcCtD
Docetaxel—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	2.06e-05	0.000194	CcSEcCtD
Docetaxel—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	2.05e-05	0.000194	CcSEcCtD
Docetaxel—Rash—Vincristine—peripheral nervous system neoplasm	2.05e-05	0.000193	CcSEcCtD
Docetaxel—Dermatitis—Vincristine—peripheral nervous system neoplasm	2.05e-05	0.000193	CcSEcCtD
Docetaxel—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	2.05e-05	0.000193	CcSEcCtD
Docetaxel—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	2.04e-05	0.000193	CcSEcCtD
Docetaxel—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	2.04e-05	0.000192	CcSEcCtD
Docetaxel—Headache—Vincristine—peripheral nervous system neoplasm	2.04e-05	0.000192	CcSEcCtD
Docetaxel—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	2.03e-05	0.000191	CcSEcCtD
Docetaxel—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	2.02e-05	0.000191	CcSEcCtD
Docetaxel—Nausea—Alitretinoin—peripheral nervous system neoplasm	2e-05	0.000189	CcSEcCtD
Docetaxel—Visual impairment—Epirubicin—peripheral nervous system neoplasm	2e-05	0.000189	CcSEcCtD
Docetaxel—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	2e-05	0.000188	CcSEcCtD
Docetaxel—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	1.97e-05	0.000185	CcSEcCtD
Docetaxel—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	1.97e-05	0.000185	CcSEcCtD
Docetaxel—Eye disorder—Epirubicin—peripheral nervous system neoplasm	1.94e-05	0.000183	CcSEcCtD
Docetaxel—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	1.94e-05	0.000183	CcSEcCtD
Docetaxel—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	1.93e-05	0.000182	CcSEcCtD
Docetaxel—Nausea—Vincristine—peripheral nervous system neoplasm	1.93e-05	0.000182	CcSEcCtD
Docetaxel—Flushing—Epirubicin—peripheral nervous system neoplasm	1.93e-05	0.000182	CcSEcCtD
Docetaxel—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	1.93e-05	0.000182	CcSEcCtD
Docetaxel—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	1.93e-05	0.000182	CcSEcCtD
Docetaxel—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	1.92e-05	0.000181	CcSEcCtD
Docetaxel—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	1.92e-05	0.000181	CcSEcCtD
Docetaxel—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	1.91e-05	0.00018	CcSEcCtD
Docetaxel—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	1.91e-05	0.00018	CcSEcCtD
Docetaxel—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	1.9e-05	0.000179	CcSEcCtD
Docetaxel—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	1.89e-05	0.000179	CcSEcCtD
Docetaxel—Asthenia—Etoposide—peripheral nervous system neoplasm	1.89e-05	0.000178	CcSEcCtD
Docetaxel—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	1.89e-05	0.000178	CcSEcCtD
Docetaxel—Angiopathy—Epirubicin—peripheral nervous system neoplasm	1.89e-05	0.000178	CcSEcCtD
Docetaxel—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	1.89e-05	0.000178	CcSEcCtD
Docetaxel—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	1.88e-05	0.000177	CcSEcCtD
Docetaxel—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	1.87e-05	0.000177	CcSEcCtD
Docetaxel—Chills—Epirubicin—peripheral nervous system neoplasm	1.86e-05	0.000176	CcSEcCtD
Docetaxel—Pruritus—Etoposide—peripheral nervous system neoplasm	1.86e-05	0.000176	CcSEcCtD
Docetaxel—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	1.86e-05	0.000175	CcSEcCtD
Docetaxel—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	1.85e-05	0.000175	CcSEcCtD
Docetaxel—Alopecia—Epirubicin—peripheral nervous system neoplasm	1.84e-05	0.000173	CcSEcCtD
Docetaxel—Vomiting—Cisplatin—peripheral nervous system neoplasm	1.83e-05	0.000172	CcSEcCtD
Docetaxel—Mental disorder—Epirubicin—peripheral nervous system neoplasm	1.82e-05	0.000172	CcSEcCtD
Docetaxel—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	1.82e-05	0.000171	CcSEcCtD
Docetaxel—Rash—Cisplatin—peripheral nervous system neoplasm	1.81e-05	0.000171	CcSEcCtD
Docetaxel—Dermatitis—Cisplatin—peripheral nervous system neoplasm	1.81e-05	0.000171	CcSEcCtD
Docetaxel—Erythema—Epirubicin—peripheral nervous system neoplasm	1.81e-05	0.000171	CcSEcCtD
Docetaxel—Malnutrition—Epirubicin—peripheral nervous system neoplasm	1.81e-05	0.000171	CcSEcCtD
Docetaxel—Diarrhoea—Etoposide—peripheral nervous system neoplasm	1.8e-05	0.00017	CcSEcCtD
Docetaxel—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	1.8e-05	0.000169	CcSEcCtD
Docetaxel—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	1.78e-05	0.000168	CcSEcCtD
Docetaxel—Flushing—Doxorubicin—peripheral nervous system neoplasm	1.78e-05	0.000168	CcSEcCtD
Docetaxel—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	1.77e-05	0.000167	CcSEcCtD
Docetaxel—Back pain—Epirubicin—peripheral nervous system neoplasm	1.75e-05	0.000165	CcSEcCtD
Docetaxel—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	1.74e-05	0.000165	CcSEcCtD
Docetaxel—Dizziness—Etoposide—peripheral nervous system neoplasm	1.74e-05	0.000164	CcSEcCtD
Docetaxel—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	1.74e-05	0.000164	CcSEcCtD
Docetaxel—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	1.74e-05	0.000164	CcSEcCtD
Docetaxel—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	1.73e-05	0.000163	CcSEcCtD
Docetaxel—Chills—Doxorubicin—peripheral nervous system neoplasm	1.73e-05	0.000163	CcSEcCtD
Docetaxel—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	1.72e-05	0.000162	CcSEcCtD
Docetaxel—Nausea—Cisplatin—peripheral nervous system neoplasm	1.71e-05	0.000161	CcSEcCtD
Docetaxel—Alopecia—Doxorubicin—peripheral nervous system neoplasm	1.7e-05	0.00016	CcSEcCtD
Docetaxel—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	1.68e-05	0.000159	CcSEcCtD
Docetaxel—Vomiting—Etoposide—peripheral nervous system neoplasm	1.67e-05	0.000158	CcSEcCtD
Docetaxel—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	1.67e-05	0.000158	CcSEcCtD
Docetaxel—Erythema—Doxorubicin—peripheral nervous system neoplasm	1.67e-05	0.000158	CcSEcCtD
Docetaxel—Anaemia—Epirubicin—peripheral nervous system neoplasm	1.67e-05	0.000158	CcSEcCtD
Docetaxel—Rash—Etoposide—peripheral nervous system neoplasm	1.66e-05	0.000157	CcSEcCtD
Docetaxel—Dermatitis—Etoposide—peripheral nervous system neoplasm	1.66e-05	0.000156	CcSEcCtD
Docetaxel—Headache—Etoposide—peripheral nervous system neoplasm	1.65e-05	0.000156	CcSEcCtD
Docetaxel—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	1.64e-05	0.000155	CcSEcCtD
Docetaxel—Syncope—Epirubicin—peripheral nervous system neoplasm	1.62e-05	0.000153	CcSEcCtD
Docetaxel—Leukopenia—Epirubicin—peripheral nervous system neoplasm	1.62e-05	0.000153	CcSEcCtD
Docetaxel—Back pain—Doxorubicin—peripheral nervous system neoplasm	1.62e-05	0.000153	CcSEcCtD
Docetaxel—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	1.61e-05	0.000152	CcSEcCtD
Docetaxel—Palpitations—Epirubicin—peripheral nervous system neoplasm	1.6e-05	0.000151	CcSEcCtD
Docetaxel—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	1.59e-05	0.00015	CcSEcCtD
Docetaxel—Cough—Epirubicin—peripheral nervous system neoplasm	1.58e-05	0.000149	CcSEcCtD
Docetaxel—Convulsion—Epirubicin—peripheral nervous system neoplasm	1.57e-05	0.000148	CcSEcCtD
Docetaxel—Nausea—Etoposide—peripheral nervous system neoplasm	1.56e-05	0.000148	CcSEcCtD
Docetaxel—Hypertension—Epirubicin—peripheral nervous system neoplasm	1.56e-05	0.000147	CcSEcCtD
Docetaxel—Anaemia—Doxorubicin—peripheral nervous system neoplasm	1.55e-05	0.000146	CcSEcCtD
Docetaxel—Arthralgia—Epirubicin—peripheral nervous system neoplasm	1.54e-05	0.000145	CcSEcCtD
Docetaxel—Myalgia—Epirubicin—peripheral nervous system neoplasm	1.54e-05	0.000145	CcSEcCtD
Docetaxel—Chest pain—Epirubicin—peripheral nervous system neoplasm	1.54e-05	0.000145	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	1.53e-05	0.000144	CcSEcCtD
Docetaxel—Dry mouth—Epirubicin—peripheral nervous system neoplasm	1.51e-05	0.000142	CcSEcCtD
Docetaxel—Syncope—Doxorubicin—peripheral nervous system neoplasm	1.5e-05	0.000142	CcSEcCtD
Docetaxel—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	1.5e-05	0.000141	CcSEcCtD
Docetaxel—Confusional state—Epirubicin—peripheral nervous system neoplasm	1.49e-05	0.00014	CcSEcCtD
Docetaxel—Palpitations—Doxorubicin—peripheral nervous system neoplasm	1.48e-05	0.000139	CcSEcCtD
Docetaxel—Oedema—Epirubicin—peripheral nervous system neoplasm	1.48e-05	0.000139	CcSEcCtD
Docetaxel—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	1.48e-05	0.000139	CcSEcCtD
Docetaxel—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	1.47e-05	0.000139	CcSEcCtD
Docetaxel—Infection—Epirubicin—peripheral nervous system neoplasm	1.47e-05	0.000138	CcSEcCtD
Docetaxel—Cough—Doxorubicin—peripheral nervous system neoplasm	1.46e-05	0.000138	CcSEcCtD
Docetaxel—Shock—Epirubicin—peripheral nervous system neoplasm	1.45e-05	0.000137	CcSEcCtD
Docetaxel—Convulsion—Doxorubicin—peripheral nervous system neoplasm	1.45e-05	0.000137	CcSEcCtD
Docetaxel—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	1.45e-05	0.000137	CcSEcCtD
Docetaxel—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	1.45e-05	0.000136	CcSEcCtD
Docetaxel—Hypertension—Doxorubicin—peripheral nervous system neoplasm	1.45e-05	0.000136	CcSEcCtD
Docetaxel—Tachycardia—Epirubicin—peripheral nervous system neoplasm	1.44e-05	0.000136	CcSEcCtD
Docetaxel—Skin disorder—Epirubicin—peripheral nervous system neoplasm	1.43e-05	0.000135	CcSEcCtD
Docetaxel—Chest pain—Doxorubicin—peripheral nervous system neoplasm	1.43e-05	0.000134	CcSEcCtD
Docetaxel—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	1.43e-05	0.000134	CcSEcCtD
Docetaxel—Myalgia—Doxorubicin—peripheral nervous system neoplasm	1.43e-05	0.000134	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	1.42e-05	0.000133	CcSEcCtD
Docetaxel—Anorexia—Epirubicin—peripheral nervous system neoplasm	1.41e-05	0.000133	CcSEcCtD
Docetaxel—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	1.39e-05	0.000131	CcSEcCtD
Docetaxel—Hypotension—Epirubicin—peripheral nervous system neoplasm	1.38e-05	0.00013	CcSEcCtD
Docetaxel—Confusional state—Doxorubicin—peripheral nervous system neoplasm	1.38e-05	0.00013	CcSEcCtD
Docetaxel—Oedema—Doxorubicin—peripheral nervous system neoplasm	1.37e-05	0.000129	CcSEcCtD
Docetaxel—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	1.37e-05	0.000129	CcSEcCtD
Docetaxel—Infection—Doxorubicin—peripheral nervous system neoplasm	1.36e-05	0.000128	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	1.35e-05	0.000127	CcSEcCtD
Docetaxel—Shock—Doxorubicin—peripheral nervous system neoplasm	1.34e-05	0.000127	CcSEcCtD
Docetaxel—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	1.34e-05	0.000126	CcSEcCtD
Docetaxel—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	1.34e-05	0.000126	CcSEcCtD
Docetaxel—Insomnia—Epirubicin—peripheral nervous system neoplasm	1.34e-05	0.000126	CcSEcCtD
Docetaxel—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	1.33e-05	0.000126	CcSEcCtD
Docetaxel—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	1.33e-05	0.000125	CcSEcCtD
Docetaxel—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	1.33e-05	0.000125	CcSEcCtD
Docetaxel—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	1.32e-05	0.000124	CcSEcCtD
Docetaxel—Somnolence—Epirubicin—peripheral nervous system neoplasm	1.31e-05	0.000124	CcSEcCtD
Docetaxel—Anorexia—Doxorubicin—peripheral nervous system neoplasm	1.3e-05	0.000123	CcSEcCtD
Docetaxel—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	1.3e-05	0.000123	CcSEcCtD
Docetaxel—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	1.28e-05	0.000121	CcSEcCtD
Docetaxel—Hypotension—Doxorubicin—peripheral nervous system neoplasm	1.28e-05	0.00012	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	1.27e-05	0.00012	CcSEcCtD
Docetaxel—Fatigue—Epirubicin—peripheral nervous system neoplasm	1.27e-05	0.00012	CcSEcCtD
Docetaxel—Pain—Epirubicin—peripheral nervous system neoplasm	1.26e-05	0.000119	CcSEcCtD
Docetaxel—Constipation—Epirubicin—peripheral nervous system neoplasm	1.26e-05	0.000119	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	1.24e-05	0.000117	CcSEcCtD
Docetaxel—Insomnia—Doxorubicin—peripheral nervous system neoplasm	1.24e-05	0.000117	CcSEcCtD
Docetaxel—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	1.23e-05	0.000116	CcSEcCtD
Docetaxel—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	1.22e-05	0.000115	CcSEcCtD
Docetaxel—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	1.22e-05	0.000115	CcSEcCtD
Docetaxel—Somnolence—Doxorubicin—peripheral nervous system neoplasm	1.21e-05	0.000115	CcSEcCtD
Docetaxel—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	1.21e-05	0.000114	CcSEcCtD
Docetaxel—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	1.2e-05	0.000113	CcSEcCtD
Docetaxel—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	1.19e-05	0.000112	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	1.18e-05	0.000111	CcSEcCtD
Docetaxel—Fatigue—Doxorubicin—peripheral nervous system neoplasm	1.18e-05	0.000111	CcSEcCtD
Docetaxel—Pain—Doxorubicin—peripheral nervous system neoplasm	1.17e-05	0.00011	CcSEcCtD
Docetaxel—Constipation—Doxorubicin—peripheral nervous system neoplasm	1.17e-05	0.00011	CcSEcCtD
Docetaxel—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	1.17e-05	0.00011	CcSEcCtD
Docetaxel—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	1.17e-05	0.00011	CcSEcCtD
Docetaxel—EGFR—DAP12 interactions—NRAS—peripheral nervous system neoplasm	1.13e-05	0.000247	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—NRAS—peripheral nervous system neoplasm	1.13e-05	0.000247	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—NRAS—peripheral nervous system neoplasm	1.13e-05	0.000247	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.13e-05	0.000246	CbGpPWpGaD
Docetaxel—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	1.13e-05	0.000106	CcSEcCtD
Docetaxel—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	1.12e-05	0.000245	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—NRAS—peripheral nervous system neoplasm	1.12e-05	0.000244	CbGpPWpGaD
Docetaxel—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	1.12e-05	0.000105	CcSEcCtD
Docetaxel—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	1.11e-05	0.000243	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.11e-05	0.000243	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—NRAS—peripheral nervous system neoplasm	1.11e-05	0.000242	CbGpPWpGaD
Docetaxel—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—peripheral nervous system neoplasm	1.11e-05	0.000242	CbGpPWpGaD
Docetaxel—EGFR—ErbB1 downstream signaling—AKT1—peripheral nervous system neoplasm	1.11e-05	0.000242	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—NRAS—peripheral nervous system neoplasm	1.1e-05	0.000241	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—MYC—peripheral nervous system neoplasm	1.1e-05	0.000239	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.1e-05	0.000239	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ENO2—peripheral nervous system neoplasm	1.09e-05	0.000239	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PPP3R1—peripheral nervous system neoplasm	1.09e-05	0.000238	CbGpPWpGaD
Docetaxel—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	1.09e-05	0.000103	CcSEcCtD
Docetaxel—GHRHR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.09e-05	0.000237	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.08e-05	0.000237	CbGpPWpGaD
Docetaxel—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	1.08e-05	0.000102	CcSEcCtD
Docetaxel—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	1.08e-05	0.000102	CcSEcCtD
Docetaxel—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	1.08e-05	0.000235	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.07e-05	0.000234	CbGpPWpGaD
Docetaxel—KIF11—Immune System—AKT1—peripheral nervous system neoplasm	1.07e-05	0.000233	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	1.07e-05	0.000233	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	1.07e-05	0.000233	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.06e-05	0.000232	CbGpPWpGaD
Docetaxel—Asthenia—Epirubicin—peripheral nervous system neoplasm	1.06e-05	9.99e-05	CcSEcCtD
Docetaxel—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.05e-05	0.00023	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	1.05e-05	0.000229	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	1.05e-05	0.000229	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—NRAS—peripheral nervous system neoplasm	1.05e-05	0.000228	CbGpPWpGaD
Docetaxel—Pruritus—Epirubicin—peripheral nervous system neoplasm	1.04e-05	9.85e-05	CcSEcCtD
Docetaxel—EGFR—Direct p53 effectors—TP53—peripheral nervous system neoplasm	1.04e-05	0.000228	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	1.04e-05	0.000226	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	1.03e-05	0.000224	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	1.01e-05	0.000221	CbGpPWpGaD
Docetaxel—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	1.01e-05	9.53e-05	CcSEcCtD
Docetaxel—EGFR—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.01e-05	0.00022	CbGpPWpGaD
Docetaxel—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	1.01e-05	9.49e-05	CcSEcCtD
Docetaxel—EGFR—Disease—PPP3R1—peripheral nervous system neoplasm	1.01e-05	0.000219	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—NRAS—peripheral nervous system neoplasm	1e-05	0.000218	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.95e-06	0.000217	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—HRAS—peripheral nervous system neoplasm	9.91e-06	0.000216	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	9.9e-06	0.000216	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HGF—peripheral nervous system neoplasm	9.86e-06	0.000215	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	9.81e-06	0.000214	CbGpPWpGaD
Docetaxel—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.8e-06	9.24e-05	CcSEcCtD
Docetaxel—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.76e-06	9.21e-05	CcSEcCtD
Docetaxel—BCL2—Innate Immune System—ERBB2—peripheral nervous system neoplasm	9.76e-06	0.000213	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	9.67e-06	0.000211	CbGpPWpGaD
Docetaxel—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.67e-06	9.11e-05	CcSEcCtD
Docetaxel—EGFR—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.65e-06	0.000211	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NCAM1—peripheral nervous system neoplasm	9.62e-06	0.00021	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—HRAS—peripheral nervous system neoplasm	9.49e-06	0.000207	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.43e-06	0.000206	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—MYC—peripheral nervous system neoplasm	9.39e-06	0.000205	CbGpPWpGaD
Docetaxel—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.39e-06	8.85e-05	CcSEcCtD
Docetaxel—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.35e-06	8.81e-05	CcSEcCtD
Docetaxel—EGFR—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	9.34e-06	0.000204	CbGpPWpGaD
Docetaxel—Rash—Epirubicin—peripheral nervous system neoplasm	9.31e-06	8.78e-05	CcSEcCtD
Docetaxel—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.3e-06	8.77e-05	CcSEcCtD
Docetaxel—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.25e-06	0.000202	CbGpPWpGaD
Docetaxel—Headache—Epirubicin—peripheral nervous system neoplasm	9.25e-06	8.72e-05	CcSEcCtD
Docetaxel—SLCO1B3—Metabolism—BCHE—peripheral nervous system neoplasm	9.25e-06	0.000202	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	9.24e-06	0.000202	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—CASP3—peripheral nervous system neoplasm	9.18e-06	0.0002	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—ERBB2—peripheral nervous system neoplasm	9.16e-06	0.0002	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.1e-06	0.000199	CbGpPWpGaD
Docetaxel—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.03e-06	8.52e-05	CcSEcCtD
Docetaxel—EGFR—MAPK Signaling Pathway—TP53—peripheral nervous system neoplasm	9.01e-06	0.000197	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MET—peripheral nervous system neoplasm	8.94e-06	0.000195	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—HRAS—peripheral nervous system neoplasm	8.92e-06	0.000195	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—HRAS—peripheral nervous system neoplasm	8.87e-06	0.000194	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—HRAS—peripheral nervous system neoplasm	8.87e-06	0.000194	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—HRAS—peripheral nervous system neoplasm	8.83e-06	0.000193	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.82e-06	0.000193	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—HRAS—peripheral nervous system neoplasm	8.79e-06	0.000192	CbGpPWpGaD
Docetaxel—Nausea—Epirubicin—peripheral nervous system neoplasm	8.77e-06	8.27e-05	CcSEcCtD
Docetaxel—EGFR—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	8.75e-06	0.000191	CbGpPWpGaD
Docetaxel—EGFR—Disease—ENO2—peripheral nervous system neoplasm	8.71e-06	0.00019	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	8.71e-06	0.00019	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—TH—peripheral nervous system neoplasm	8.7e-06	0.00019	CbGpPWpGaD
Docetaxel—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.69e-06	8.19e-05	CcSEcCtD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—peripheral nervous system neoplasm	8.66e-06	0.000189	CbGpPWpGaD
Docetaxel—Rash—Doxorubicin—peripheral nervous system neoplasm	8.61e-06	8.12e-05	CcSEcCtD
Docetaxel—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.61e-06	8.12e-05	CcSEcCtD
Docetaxel—Headache—Doxorubicin—peripheral nervous system neoplasm	8.56e-06	8.07e-05	CcSEcCtD
Docetaxel—GHRHR—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.48e-06	0.000185	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.41e-06	0.000183	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—AKT1—peripheral nervous system neoplasm	8.38e-06	0.000183	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	8.29e-06	0.000181	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—PTPN11—peripheral nervous system neoplasm	8.27e-06	0.00018	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—HRAS—peripheral nervous system neoplasm	8.27e-06	0.00018	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—peripheral nervous system neoplasm	8.27e-06	0.00018	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—HRAS—peripheral nervous system neoplasm	8.27e-06	0.00018	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	8.24e-06	0.00018	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—HRAS—peripheral nervous system neoplasm	8.19e-06	0.000179	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	8.13e-06	0.000177	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	8.12e-06	0.000177	CbGpPWpGaD
Docetaxel—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.12e-06	7.65e-05	CcSEcCtD
Docetaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	8.11e-06	0.000177	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—HRAS—peripheral nervous system neoplasm	8.08e-06	0.000176	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	8.05e-06	0.000176	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	7.96e-06	0.000174	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—AKT1—peripheral nervous system neoplasm	7.87e-06	0.000172	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—AKT1—peripheral nervous system neoplasm	7.83e-06	0.000171	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	7.83e-06	0.000171	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—HRAS—peripheral nervous system neoplasm	7.81e-06	0.00017	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	7.8e-06	0.00017	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—MYC—peripheral nervous system neoplasm	7.78e-06	0.00017	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—AKT1—peripheral nervous system neoplasm	7.76e-06	0.000169	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	7.74e-06	0.000169	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	7.72e-06	0.000169	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—peripheral nervous system neoplasm	7.71e-06	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—NRAS—peripheral nervous system neoplasm	7.7e-06	0.000168	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.67e-06	0.000167	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.66e-06	0.000167	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—HRAS—peripheral nervous system neoplasm	7.65e-06	0.000167	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	7.65e-06	0.000167	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.63e-06	0.000167	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—AKT1—peripheral nervous system neoplasm	7.61e-06	0.000166	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IFNB1—peripheral nervous system neoplasm	7.55e-06	0.000165	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ENO2—peripheral nervous system neoplasm	7.49e-06	0.000163	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	7.45e-06	0.000163	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	7.43e-06	0.000162	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—NRAS—peripheral nervous system neoplasm	7.43e-06	0.000162	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	7.32e-06	0.00016	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PTPN11—peripheral nervous system neoplasm	7.3e-06	0.000159	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—AKT1—peripheral nervous system neoplasm	7.3e-06	0.000159	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	7.3e-06	0.000159	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	7.3e-06	0.000159	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	7.23e-06	0.000158	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PTPN11—peripheral nervous system neoplasm	7.19e-06	0.000157	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	7.17e-06	0.000156	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	7.14e-06	0.000156	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—MYC—peripheral nervous system neoplasm	7.12e-06	0.000155	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GNAS—peripheral nervous system neoplasm	7.1e-06	0.000155	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	7.07e-06	0.000154	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	7.05e-06	0.000154	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.04e-06	0.000154	CbGpPWpGaD
Docetaxel—EGFR—Disease—SLC2A1—peripheral nervous system neoplasm	7.02e-06	0.000153	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	7.01e-06	0.000153	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ABCB1—peripheral nervous system neoplasm	6.97e-06	0.000152	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—NRAS—peripheral nervous system neoplasm	6.97e-06	0.000152	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.96e-06	0.000152	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—AKT1—peripheral nervous system neoplasm	6.9e-06	0.000151	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.87e-06	0.00015	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	6.81e-06	0.000149	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—AKT1—peripheral nervous system neoplasm	6.75e-06	0.000147	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	6.75e-06	0.000147	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.7e-06	0.000146	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.66e-06	0.000145	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	6.54e-06	0.000143	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—ERBB2—peripheral nervous system neoplasm	6.53e-06	0.000143	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	6.46e-06	0.000141	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	6.4e-06	0.00014	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—peripheral nervous system neoplasm	6.39e-06	0.00014	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—MYC—peripheral nervous system neoplasm	6.37e-06	0.000139	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.34e-06	0.000138	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—BCHE—peripheral nervous system neoplasm	6.33e-06	0.000138	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.24e-06	0.000136	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	6.15e-06	0.000134	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	6.08e-06	0.000133	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.03e-06	0.000132	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—TH—peripheral nervous system neoplasm	5.95e-06	0.00013	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.88e-06	0.000128	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—peripheral nervous system neoplasm	5.85e-06	0.000128	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HGF—peripheral nervous system neoplasm	5.83e-06	0.000127	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	5.83e-06	0.000127	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—ERBB2—peripheral nervous system neoplasm	5.77e-06	0.000126	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	5.75e-06	0.000126	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	5.7e-06	0.000124	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ERBB2—peripheral nervous system neoplasm	5.68e-06	0.000124	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—HRAS—peripheral nervous system neoplasm	5.63e-06	0.000123	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	5.61e-06	0.000122	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	5.54e-06	0.000121	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.49e-06	0.00012	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.44e-06	0.000119	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—HRAS—peripheral nervous system neoplasm	5.43e-06	0.000119	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	5.41e-06	0.000118	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	5.36e-06	0.000117	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.29e-06	0.000115	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.18e-06	0.000113	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.1e-06	0.000111	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—HRAS—peripheral nervous system neoplasm	5.1e-06	0.000111	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	5.02e-06	0.00011	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5e-06	0.000109	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—AKT1—peripheral nervous system neoplasm	4.97e-06	0.000109	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—NRAS—peripheral nervous system neoplasm	4.97e-06	0.000108	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.93e-06	0.000108	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	4.88e-06	0.000107	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GNAS—peripheral nervous system neoplasm	4.85e-06	0.000106	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—AKT1—peripheral nervous system neoplasm	4.8e-06	0.000105	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.76e-06	0.000104	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.65e-06	0.000102	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.52e-06	9.87e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	4.42e-06	9.64e-05	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—AKT1—peripheral nervous system neoplasm	4.42e-06	9.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—NRAS—peripheral nervous system neoplasm	4.39e-06	9.58e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	4.38e-06	9.56e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.33e-06	9.46e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NRAS—peripheral nervous system neoplasm	4.32e-06	9.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.31e-06	9.41e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	4.3e-06	9.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTPN11—peripheral nervous system neoplasm	4.25e-06	9.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	4.22e-06	9.2e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	4.17e-06	9.09e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	4.12e-06	9e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.1e-06	8.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.96e-06	8.63e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.93e-06	8.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTPN11—peripheral nervous system neoplasm	3.93e-06	8.57e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	3.88e-06	8.46e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	3.74e-06	8.17e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	3.68e-06	8.04e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—peripheral nervous system neoplasm	3.64e-06	7.94e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	3.59e-06	7.84e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.47e-06	7.57e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	3.46e-06	7.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ERBB2—peripheral nervous system neoplasm	3.36e-06	7.34e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	3.29e-06	7.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—peripheral nervous system neoplasm	3.21e-06	7.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.21e-06	7.01e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	3.16e-06	6.91e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—peripheral nervous system neoplasm	3.16e-06	6.91e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	3.11e-06	6.79e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	3.11e-06	6.78e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB2—peripheral nervous system neoplasm	3.1e-06	6.77e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	3.08e-06	6.73e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.97e-06	6.48e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	2.93e-06	6.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—peripheral nervous system neoplasm	2.84e-06	6.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.8e-06	6.11e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—peripheral nervous system neoplasm	2.79e-06	6.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.75e-06	6e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	2.72e-06	5.94e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NRAS—peripheral nervous system neoplasm	2.56e-06	5.58e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	2.5e-06	5.47e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	2.39e-06	5.21e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NRAS—peripheral nervous system neoplasm	2.36e-06	5.15e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—peripheral nervous system neoplasm	2.33e-06	5.09e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.27e-06	4.95e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—peripheral nervous system neoplasm	2.2e-06	4.8e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.17e-06	4.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.05e-06	4.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.97e-06	4.3e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.92e-06	4.18e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—peripheral nervous system neoplasm	1.92e-06	4.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—peripheral nervous system neoplasm	1.87e-06	4.08e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	1.83e-06	4e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.83e-06	3.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.81e-06	3.95e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.8e-06	3.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—peripheral nervous system neoplasm	1.73e-06	3.77e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.65e-06	3.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—peripheral nervous system neoplasm	1.65e-06	3.6e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	1.62e-06	3.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.54e-06	3.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—peripheral nervous system neoplasm	1.52e-06	3.33e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.47e-06	3.21e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.44e-06	3.15e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	1.35e-06	2.96e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—peripheral nervous system neoplasm	1.31e-06	2.86e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.26e-06	2.76e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.21e-06	2.64e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	1.19e-06	2.6e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	1.18e-06	2.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.07e-06	2.33e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	8.54e-07	1.86e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	6.45e-07	1.41e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	3.97e-07	8.67e-06	CbGpPWpGaD
